Results

Total Results: 685 records

Showing results for "cardiovascular".
Users also searched for: statin

21. Ventricular Arrhythmias and Cerebrovascular Events in the Elderly Using Conventional and Atypical Antipsychotic Medications | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/antipsychotic-medicine-cardiovascular-elderly/research

22. Dietary-Supplements Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
    April 01, 2012 - Clinical cardiovascular effectiveness/ efficacy outcomes (e.g., mortality and specific cardiovascular … cardiovascular outcomes? … cardiovascular outcomes? … cardiovascular medication(s) … cardiovascular outcomes?

23. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - specific dietary supplements (when compared to cardiovascular drugs alone or cardiovascular drugs and … cardiovascular outcomes? … cardiovascular outcomes? … drug or one specific class of cardiovascular drugs as defined in Appendix 1. … Use of complementary therapies in patients with cardiovascular disease.

24. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0086_04-01-2009.pdf
    January 01, 2009 - Results of Topic Selection Process & Next Steps  Dietary supplements in the elderly taking cardiovascular … Nomination Summary: The nominator is interested in the risks and benefits to elderly patients on cardiovascular … For the elderly taking cardiovascular medications, what are the comparative risks and benefits of commonly … )  Cardiovascular disease is a major cause of morbidity and mortality in the elderly. … Dietary Supplements in the Elderly Taking Cardiovascular Medications Nomination Summary Document

25. Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Undergoing Insertion of Implantable Cardiovascular Devices (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-cardio-dental.pdf
    July 01, 2023 - Efficacy of Dental Services for Reducing Adverse Events in Those Undergoing Insertion of Implantable Cardiovascular … Efficacy of Dental Services for Reducing Adverse Events in Those Undergoing Insertion of Implantable Cardiovascular … Background Implantable devices are an important part of treatment regimens for serious cardiovascular … The primary question for this review is: For those undergoing insertion of implantable cardiovascular … Cardiovascular Medicine. 2017 12/20/2017;20(12):285-92. doi: https://doi.org/10.4414/cvm.2017.00532

26. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
    March 01, 2009 - Of 3,821 total deaths within the first 180 day of use, cardiovascular (CV) deaths accounted for 49% … , out-of-hospital (OOH) cardiovascular, overall infection, and pneumonia. … Among 3,821 non-cancer deaths, 1,866 (49%) were cardiovascular, and greater than 60% of the cardiovascular … Hazard ratios comparing the rate of cardiovascular death for new users of conventional vs. … Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors.

27. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
    October 01, 2009 - Layout 1 Background Nearly 2,400 Americans die of cardiovascular disease each day, an average of one … Cardiovascular disease claims more lives each year than cancer, chronic lower respiratory diseases, accidents … Since 1900, cardiovascular disease has accounted for more deaths than any other single cause or group … The TRANSCEND (Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular … Composite of High • ACE inhibitor or ARB therapy is better than placebo in cardiovascular mortality,

28. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
    January 01, 2011 - walking time and distance; improved wound healing; decreased rates of amputation; decreased rates of cardiovascular … Does aspirin reduce the risk of adverse cardiovascular events (MI, stroke, cardiovascular death) in … Is clopidogrel more effective than aspirin in reducing adverse cardiovascular events in PAD? 3. … )  PAD is a prevalent disease associated with an increased risk of cardiovascular events.

29. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
    January 01, 2010 - response to clopidogrel in patients (1) with acute coronary syndromes, (2) who have suffered other cardiovascular … PICO Population(s): (1) Patients with acute coronary syndrome, (2) patients who have suffered other cardiovascular … Outcome(s): Recurrent ischemic events, stent thromboses, cardiovascular disease- related morbidity and … treatment choice for patients who require antiplatelet therapy for the prevention of major adverse cardiovascular … )  While clopidogrel may decrease morbidity and mortality associated with several cardiovascular

30. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-heart_research-protocol.pdf
    April 18, 2012 - disease (CVD).6,7 Modifiable cardiovascular risk factors for poor health, such as smoking,8 obesity … disease, elevated cardiovascular risk (e.g., hypertension), or are taking antipsychotics? … risk Abbreviations: CVD = cardiovascular disease; KQ = key question IV. … Abbreviations: CVD = cardiovascular disease; KQ = key question 11 B. … Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study.

31. Peripheral-Artery-Disease-Treatment Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
    May 01, 2013 - events (e.g., all- cause mortality, myocardial infarction, stroke, cardiovascular death), functional … events (e.g., all-cause mortality, myocardial infarction, stroke, cardiovascular death), amputation … events (e.g., all-cause mortality, myocardial infarction, stroke, cardiovascular death), amputation … Cardiovascular mortality SOE=Low 1 RCT, 3,096 patients HR 0.92 (0.66 to 1.29) No difference. … Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories.

32. Update Topic Brief CER 27 NSD FINAL_SJ final (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
    January 17, 2014 - • All-cause mortality • Cardiovascular mortality • Cardiovascular and cerebrovascular morbidity … type 2 diabetes, in particular for adults age 65 or older, in terms of mortality, hypoglycemia, and cardiovascular … There have been a number of potential adverse events associated with rosiglitazone (e.g. increased cardiovascular

33. Dietary-Supplements Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
    January 01, 2013 - Clinical cardiovascular effectiveness/ efficacy outcomes (e.g., mortality and specific cardiovascular … Intermediate cardiovascular efficacy outcomes of cardiovascular drug(s) plus supplement versus drug(s … cardiovascular efficacy outcomes? … Clinical cardiovascular effectiveness/ efficacy outcomes (e.g., mortality and specific cardiovascular … Intermediate cardiovascular efficacy outcomes of cardiovascular drug(s) plus supplement versus drug(s

34. Kidney-Disease-Medicine Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
    January 01, 2012 - disease or the combination of diabetes and other cardiovascular risk factors. … Patients who had microalbuminuria and were at high risk for cardiovascular complications may benefit … • No other cardiovascular or renal outcomes were reported. … • There was no significant difference in risk of cardiovascular mortality. … disease or had diabetes and other cardiovascular risk factors.

35. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
    October 01, 2006 - of surgery and medical treatment reported cardiovascular outcomes. … No study of medical interventions reported cardiovascular outcomes. … , it is likely that the studies were too small to detect different rates of cardiovascular events. … Cardiovascular Weak • 1 RCT found similar rates of cardiovascular events at 3 to 54 months of followup … Baseline Acceptable • Among 6 studies, a range of cardiovascular measures, including cardiovascular history

36. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
    February 01, 2009 - included other evidence of ischemic heart disease (e.g., angina, PTCA, CABG, or nitroglycerin use), other cardiovascular … Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF.Accuracy of ICD-9-CM codes for identifying cardiovascular … 65.1 Myocardial infarction 3.5 3.5 Other ischemic heart disease 29.3 24.4 Other cardiovascular … cerebrovascular disease, CHF, diabetes, MI, hypertension, other evidence of ischemic heart disease, other cardiovascular

37. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
    January 01, 2007 - Cardiovascular mortality and morbidity. … Linking these effects to cardiovascular outcomes will also help clarify the clinical relevance. … Rosiglitazone evaluated for cardiovascular outcomes–an interim analysis. N Engl J Med 2007. … Cardiovascular Low to very low It was unclear whether cardiovascular mortality differed when disease … cardiovascular morbidity differed between the medications. 2d.

38. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
    March 01, 2011 - In addition, the death rate from cardiovascular disease in adults with type 2 diabetes is two to four … Cardiovascular mortality 3. … Cardiovascular and cerebrovascular morbidity (e.g., myocardial infarction and stroke) 4. … Metformin was associated with slightly lower all-cause mortality and cardiovascular disease mortality … (continued) Cardiovascular and Low A comparison of the risk of cardiovascular morbidity between metformin

39. CER 244 Evidence Summary: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
    May 01, 2021 - High Dose Quadrivalent®, Fluzone Quadrivalent®) Low: No evidence of increased risk of asthma, cardiovascular … -valent pneumococcal conjugate (PCV13; Prevnar 13®) Moderate: No evidence of increased risk of cardiovascular … valent pneumococcal polysaccharide (PPSV23; Pneumovax®) High: No evidence of increased risk of cardiovascular … increased risk of amyotrophic lateral sclerosis, anaphylaxis or systemic allergic reaction, asthma, cardiovascular … Moderate: No evidence of increased risk of death Low: No evidence of increased risk of asthma, cardiovascular

40. Topic 0438 Risk stratification and CAD NSD FINAL_SJ-2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0520-131115.pdf
    May 29, 2025 - diagnostic strategies are known, the relative impact of these tests on clinical end points such as major cardiovascular … patient-related benefits, including but not limited to: reduction in hospitalizations, major adverse cardiovascular … catheterization without subsequent percutaneous coronary intervention, hospitalizations, major adverse cardiovascular